Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118632

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

P Clarkson, M R Adams, A J Powe, A E Donald, R McCredie, J Robinson, S N McCarthy, A Keech, D S Celermajer, and J E Deanfield

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by Clarkson, P. in: JCI | PubMed | Google Scholar

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by Adams, M. in: JCI | PubMed | Google Scholar

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by Powe, A. in: JCI | PubMed | Google Scholar

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by Donald, A. in: JCI | PubMed | Google Scholar

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by McCredie, R. in: JCI | PubMed | Google Scholar

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by Robinson, J. in: JCI | PubMed | Google Scholar

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by McCarthy, S. in: JCI | PubMed | Google Scholar

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by Keech, A. in: JCI | PubMed | Google Scholar

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by Celermajer, D. in: JCI | PubMed | Google Scholar

Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Find articles by Deanfield, J. in: JCI | PubMed | Google Scholar

Published April 15, 1996 - More info

Published in Volume 97, Issue 8 on April 15, 1996
J Clin Invest. 1996;97(8):1989–1994. https://doi.org/10.1172/JCI118632.
© 1996 The American Society for Clinical Investigation
Published April 15, 1996 - Version history
View PDF
Abstract

In hypercholesterolemic rabbits, oral L-arginine (the substrate for endothelium derived nitric oxide) attenuates endothelial dysfunction and atheroma formation, but the effect in hypercholesterolemic humans is unknown. Using high resolution external ultrasound, we studied arterial physiology in 27 hypercholesterolemic subjects aged 29+/-5 (19-40) years, with known endothelial dysfunction and LDL-cholesterol levels of 238+/-43 mg/dl. Each subject was studied before and after 4 wk of L-arginine (7 grams x 3/day) or placebo powder, with 4 wk washout, in a randomized double-blind crossover study. Brachial artery diameter was measured at rest, during increased flow (causing endothelium-dependent dilation, EDD) and after sublingual glyceryl trinitrate (causing endothelium-independent dilation). After oral L-arginine, plasma L-arginine levels rose from 115+/-103 to 231+/-125 micromol/liter (P<0.001), and EDD improved from 1.7+/-1.3 to 5.6+/-3.0% (P<0.001). In contrast there was no significant change in response to glyceryl trinitrate. After placebo there were no changes in endothelium-dependent or independent vascular responses. Lipid levels were unchanged after L-arginine and placebo. Dietary supplementation with L-arginine significantly improves EDD in hypercholesterolemic young adults, and this may impact favorably on the atherogenic process.

Version history
  • Version 1 (April 15, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts